The serotonin 1A (5-HT1A) receptor as a pharmacological target in depression
Clinical depression is a common, debilitating and heterogenous disorder. Existing treatments for depression are inadequate for a significant minority of patients and new approaches are urgently needed. A wealth of evidence implicates the serotonin 1A (5-HT1A) receptor in the pathophysiology of depre...
Hlavní autoři: | , , , |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
Springer Nature
2023
|